Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05231135 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Registry Study on HIV-related Lymphoma

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 6, 2023 (before its estimated August 31, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Secondary endpoints: details revised at 1 of 4 entriesv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.
Trial Details
NCT Number NCT05231135
Lead Sponsor Rotkreuzklinikum München gGmbH
Conditions
(from sponsor)		 AIDS Related Lymphoma, HIV Related Lymphoma
Related terms Lymphoma, Lymphoma, AIDS-Related
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov